{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:59:29Z","timestamp":1791928769559,"version":"4.3.4"},"reference-count":46,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"2","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2021,2,3]]},"DOI":"10.1167\/iovs.62.2.5","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T06:37:43Z","timestamp":1612593463000},"page":"5","source":"Crossref","is-referenced-by-count":34,"title":["VEGFR2 Trafficking by KIF13B Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration"],"prefix":"10.1167","volume":"62","author":[{"given":"Stephen B.","family":"Waters","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Zelkha","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Biophysics Core & Department of Pharmaceutical Sciences, University of Illinois College of Medicine, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrius","family":"Kazlauskas","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine, Chicago, Illinois, United States"},{"name":"Department of Physiology and Biophysics, University of Illinois College of Medicine, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"Rosenblatt","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asrar B.","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori H.","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, Illinois, United States"},{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"Folkman","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","article-title":"Basic and therapeutic aspects of angiogenesis","volume":"146","author":"Potente","year":"2011","journal-title":"Cell"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00441-008-0675-8","article-title":"VEGF inhibition: insights from preclinical and clinical studies","volume":"335","author":"Crawford","year":"2009","journal-title":"Cell Tissue Res"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.tips.2009.09.004","article-title":"Tumor and stromal pathways mediating refractoriness\/resistance to anti-angiogenic therapies","volume":"30","author":"Crawford","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrclinonc.2009.94","article-title":"Adverse effects of anticancer agents that target the VEGF pathway","volume":"6","author":"Chen","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/nm1010-1107","article-title":"Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy","volume":"16","author":"Ferrara","year":"2010","journal-title":"Nat Med"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/eye.2014.64","article-title":"Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD","volume":"28","author":"Ehlken","year":"2014","journal-title":"Eye (Lond)"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjophthalmol-2011-301236","article-title":"Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?","volume":"96","author":"Binder","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"29619","DOI":"10.1038\/srep29619","article-title":"Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: implications of serous pigment epithelial detachment","volume":"6","author":"Nagai","year":"2016","journal-title":"Sci Rep"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ajpath.2016.09.010","article-title":"Antiangiogenic therapeutic potential of peptides derived from the molecular motor KIF13B that transports VEGFR2 to plasmalemma in endothelial cells","volume":"187","author":"Yamada","year":"2017","journal-title":"Am J Pathol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1242\/jcs.156109","article-title":"KIF13B regulates angiogenesis through Golgi to plasma membrane trafficking of VEGFR2","volume":"127","author":"Yamada","year":"2014","journal-title":"J Cell Sci"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1182\/blood-2005-12-007484","article-title":"VEGF regulates the mobilization of VEGFR2\/KDR from an intracellular endothelial storage compartment","volume":"108","author":"Gampel","year":"2006","journal-title":"Blood"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1038\/ncomms2683","article-title":"VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation","volume":"4","author":"Hayashi","year":"2013","journal-title":"Nat Commun"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.devcel.2010.02.016","article-title":"VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis","volume":"18","author":"Lanahan","year":"2010","journal-title":"Dev Cell"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1182\/blood-2010-06-291690","article-title":"Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6","volume":"117","author":"Manickam","year":"2011","journal-title":"Blood"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ncb2679","article-title":"Spatial regulation of VEGF receptor endocytosis in angiogenesis","volume":"15","author":"Nakayama","year":"2013","journal-title":"Nat Cell Biol"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1083\/jcb.200602080","article-title":"Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments","volume":"174","author":"Lampugnani","year":"2006","journal-title":"J Cell Biol"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/j.1600-0854.2006.00462.x","article-title":"Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells","volume":"7","author":"Ewan","year":"2006","journal-title":"Traffic"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1600-0854.2009.01001.x","article-title":"Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis","volume":"11","author":"Bruns","year":"2010","journal-title":"Traffic"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1161\/ATVBAHA.109.186239","article-title":"Rab GTPase regulation of VEGFR2 trafficking and signaling in endothelial cells","volume":"29","author":"Jopling","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1152\/physiol.00016.2012","article-title":"An inside view: VEGF receptor trafficking and signaling","volume":"27","author":"Simons","year":"2012","journal-title":"Physiology"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1161\/01.RES.0000136522.58649.60","article-title":"IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species\u2013dependent endothelial migration and proliferation","volume":"95","author":"Yamaoka-Tojo","year":"2004","journal-title":"Circ Res"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1083\/jcb.200302047","article-title":"VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia","volume":"161","author":"Gerhardt","year":"2003","journal-title":"J Cell Biol"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/ncb2103","article-title":"Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting","volume":"12","author":"Jakobsson","year":"2010","journal-title":"Nat Cell Biol"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrm2774","article-title":"Kinesin superfamily motor proteins and intracellular transport","volume":"10","author":"Hirokawa","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"e0132643","DOI":"10.1371\/journal.pone.0132643","article-title":"Optimization of an image-guided laser-induced choroidal neovascularization model in mice","volume":"10","author":"Gong","year":"2015","journal-title":"PLoS One"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/nprot.2013.135","article-title":"Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice","volume":"8","author":"Lambert","year":"2013","journal-title":"Nat Protoc"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"e69552","DOI":"10.1371\/journal.pone.0069552","article-title":"Choroid sprouting assay: an ex vivo model of microvascular angiogenesis","volume":"8","author":"Shao","year":"2013","journal-title":"PLoS One"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1083\/jcb.200604031","article-title":"Transport of PIP3 by GAKIN, a kinesin-3 family protein, regulates neuronal cell polarity","volume":"174","author":"Horiguchi","year":"2006","journal-title":"J Cell Biol"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1167\/iovs.05-1229","article-title":"VEGF expression and receptor activation in the choroid during development and in the adult","volume":"47","author":"Saint-Geniez","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0165-022X(94)90042-6","article-title":"Determination of biotin concentration by a competitive enzyme-linked immunosorbent assay (ELISA) method","volume":"29","author":"Yuo-Sheng","year":"1994","journal-title":"J Biochem Biophys Methods"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMicm1005605","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"CATT Research Group","year":"2011","journal-title":"N Engl J Med"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"10039","DOI":"10.1021\/bi701169w","article-title":"The effector domain of human Dlg tumor suppressor acts as a switch that relieves autoinhibition of kinesin-3 motor GAKIN\/KIF13B","volume":"46","author":"Yamada","year":"2007","journal-title":"Biochemistry"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"14177","DOI":"10.1038\/ncomms14177","article-title":"KIF13B establishes a CAV1-enriched microdomain at the ciliary transition zone to promote Sonic hedgehog signalling","volume":"8","author":"Schou","year":"2017","journal-title":"Nature Communications"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"e1002440","DOI":"10.1371\/journal.pbio.1002440","article-title":"Kif13b regulates PNS and CNS myelination through the Dlg1 scaffold","volume":"14","author":"Noseda","year":"2016","journal-title":"PLoS Biol"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"e1007184","DOI":"10.1371\/journal.pgen.1007184","article-title":"Kinesin Khc-73\/KIF13B modulates retrograde BMP signaling by influencing endosomal dynamics at the Drosophila neuromuscular junction","volume":"14","author":"Liao","year":"2018","journal-title":"PLoS Genet"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201309066","article-title":"KIF13B enhances the endocytosis of LRP1 by recruiting LRP1 to caveolae","volume":"204","author":"Kanai","year":"2014","journal-title":"J Cell Biol"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1083\/jcb.201205070","article-title":"A novel split kinesin assay identifies motor proteins that interact with distinct vesicle populations","volume":"198","author":"Jenkins","year":"2012","journal-title":"J Cell Biol"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"28774","DOI":"10.1074\/jbc.M000715200","article-title":"GAKIN, a novel kinesin-like protein associates with the human homologue of the Drosophila discs large tumor suppressor in T lymphocytes","volume":"275","author":"Hanada","year":"2000","journal-title":"J Biol Chem"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.addr.2018.01.008","article-title":"Ocular delivery of proteins and peptides: challenges and novel formulation approaches","volume":"126","author":"Mandal","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ajo.2012.03.047","article-title":"Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans","volume":"154","author":"Krohne","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ajo.2008.05.036","article-title":"Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans","volume":"146","author":"Krohne","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1084\/jem.20160311","article-title":"VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation","volume":"214","author":"Fantin","year":"2017","journal-title":"J Exp Med"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2772239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:29Z","timestamp":1791927089000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2772239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.62.2.5","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,3]]}}}